Researchers translate a hypothesis into a personalized treatment for cancer

byUniversity of CalgaryFranz Zemp designed a personalized CAR T-cell therapy for a Calgary teen. Credit: Arnie Charbonneau Cancer Institute, University of CalgaryDr. Franz Zemp, Ph.D., gets chil

Updated on: January 26,2024 21

Researchers translate a hypothesis into a personalized treatment for cancer

byUniversity of CalgaryFranz Zemp designed a personalized CAR T-cell therapy for a Calgary teen. Credit: Arnie Charbonneau Cancer Institute, University of CalgaryDr. Franz Zemp, Ph.D., gets chil

Updated on:January 26,2024 21

Video educates and connects men to prostate cancer screening options

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainAs part of a comprehensive effort to improve cancer screenings among diverse communities, Penn Me

Updated on: April 28,2024 0

Video educates and connects men to prostate cancer screening options

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainAs part of a comprehensive effort to improve cancer screenings among diverse communities, Penn Me

Updated on:April 28,2024 0

A Surprising Revelation: Cancer Cells' Ability to Build "Electrical Grids" for Tumor Spread

Updated on: March 01,2025 0

A Surprising Revelation: Cancer Cells' Ability to Build "Electrical Grids" for Tumor Spread

Updated on:March 01,2025 0

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro

Updated on: March 22,2024 12

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro

Updated on:March 22,2024 12

Colorectal cancer gene implicated in broad range of solid tumors

by Amy Mone, Valerie Mehl,Johns Hopkins UniversityMUTYH-altered samples. (A) CONSORT diagram showing grouping of samples. Samples with somatic MUTYH alterations including pathogenic short varian

Updated on: March 27,2024 0

Colorectal cancer gene implicated in broad range of solid tumors

by Amy Mone, Valerie Mehl,Johns Hopkins UniversityMUTYH-altered samples. (A) CONSORT diagram showing grouping of samples. Samples with somatic MUTYH alterations including pathogenic short varian

Updated on:March 27,2024 0

Less than half of pregnant women get the flu shot: New data from UPMC Children's might change that

by Abby Mackey, Pittsburgh Post-GazetteCredit: Unsplash/CC0 Public DomainJohn Williams knows the risks associated with riding motorcycles, but they don't deter him. Neither do warnings from physic

Updated on: March 25,2024 10

Less than half of pregnant women get the flu shot: New data from UPMC Children's might change that

by Abby Mackey, Pittsburgh Post-GazetteCredit: Unsplash/CC0 Public DomainJohn Williams knows the risks associated with riding motorcycles, but they don't deter him. Neither do warnings from physic

Updated on:March 25,2024 10

Bacterium may decrease effectiveness of immunotherapy

by Béatrice St-Cyr-Leroux,University of MontrealAssociation between the H. pylori seropositivity status and clinical outcomes in 97 patients with advanced melanoma. A. Stacked barplot between H.

Updated on: January 10,2024 9

Bacterium may decrease effectiveness of immunotherapy

by Béatrice St-Cyr-Leroux,University of MontrealAssociation between the H. pylori seropositivity status and clinical outcomes in 97 patients with advanced melanoma. A. Stacked barplot between H.

Updated on:January 10,2024 9

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved

Updated on: May 26,2024 3

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved

Updated on:May 26,2024 3

Researchers discover compound that fights leukemia and lymphoma

JANUARY 12, 2024byUniversity of Texas at El PasoRenato Aguilera, Ph.D., a professor in the Department of Biological Sciences at The University of Texas at El Paso, is the principal investigator

Updated on: March 28,2024 11

Researchers discover compound that fights leukemia and lymphoma

JANUARY 12, 2024byUniversity of Texas at El PasoRenato Aguilera, Ph.D., a professor in the Department of Biological Sciences at The University of Texas at El Paso, is the principal investigator

Updated on:March 28,2024 11

Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant

byNIH/National Heart, Lung and Blood InstituteDetection and Impact of Residual Variants on Clinical Outcomes by Gene A, Heatmap illustrating for each patient (n = 1075) their cohort assignment,

Updated on: January 15,2024 10

Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant

byNIH/National Heart, Lung and Blood InstituteDetection and Impact of Residual Variants on Clinical Outcomes by Gene A, Heatmap illustrating for each patient (n = 1075) their cohort assignment,

Updated on:January 15,2024 10

Delivering oxygen to tumors may be key in overcoming radiation therapy resistance

by National Institute of Biomedical Imaging and BioengineeringOxygen in tumors is necessary for radiotherapy to effectively treat cancer, but when tumors are hypoxic, this method can fail. A new strat

Updated on: January 10,2024 10

Delivering oxygen to tumors may be key in overcoming radiation therapy resistance

by National Institute of Biomedical Imaging and BioengineeringOxygen in tumors is necessary for radiotherapy to effectively treat cancer, but when tumors are hypoxic, this method can fail. A new strat

Updated on:January 10,2024 10

Scientists develop first bone marrow model that supports human stem cells

byUniversity of GlasgowSchematic of the bone marrow (BM) niche microenvironment. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-50054-0Scientists have created the first

Updated on: August 03,2024 0

Scientists develop first bone marrow model that supports human stem cells

byUniversity of GlasgowSchematic of the bone marrow (BM) niche microenvironment. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-50054-0Scientists have created the first

Updated on:August 03,2024 0